Explore every episode of the podcast Drug Diaries

Liquid biopsies could change how we detect cancer, but what happens when you are caught in the waiting period for a diagnosis?

Jeff Bousfield shares his personal account of finding a concerning symptom and the subsequent wait for a cystoscopy. This period of medical uncertainty highlights the intense emotional toll patients experience while navigating the system.

Beyond the personal story, we look at the role of the NHS in managing these diagnostic pathways. We examine how new testing methods like liquid biopsies aim to reduce the anxiety caused by long waits and provide faster answers for those facing a potential cancer diagnosis.

Subscribe for weekly healthcare infrastructure breakdowns, and let me know in the comments how you think diagnostic wait times could be improved.

Chapters

00:00 Introduction to Nonicus and cancer diagnostics

03:28 The patient experience: Waiting and anxiety

08:03 Leadership lessons from scaling startups to pharma

16:01 Reflections on career and future aspirations

18:40 Psychological impact of invasive procedures

22:23 The role of cystoscopy and how Galeas complements it

24:25 The patient pathway: From GP to diagnosis

26:09 Speeding up diagnosis: From sample to report

28:20 Decentralized testing and NHS integration

29:31 Explaining Galeas to a 12-year-old

33:11 Detecting recurrence and early relapse

34:58 Clinical trials and data endpoints

36:54 Test accuracy and predictive values

39:23 False positives and improving confidence

40:21 Analogy of airport security screening

41:07 Operational challenges in scaling up

44:23 Experience from COVID testing scale-up

47:37 The Birmingham ecosystem and Life Sciences Week

48:21 Core message for the upcoming event

49:21 Closing remarks and future outlook

Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

Why is the UK a global leader in scientific discovery? Prof Chris Molloy joins us to discuss the future of UK life sciences.

The UK has long been at the forefront of global invention, anchored by a unique network of world-leading universities and brilliant research talent. This conversation examines the foundations of that success and why the current environment remains so fertile for groundbreaking scientific discovery.

We also look at the entrepreneurs converting these academic breakthroughs into tangible solutions. It is about more than just research; it is about building sustainable biotech startups capable of delivering real-world medical innovation that has the potential to save millions of lives.

Subscribe for weekly insights on the business of healthcare, and let me know in the comments if you believe the UK can maintain its competitive edge in research.

Chapters

00:00 The threat and opportunity in UK science

00:27 Why innovation needs to stay in the UK

01:24 What kind of life sciences nation does the UK want to be?

02:22 Professor Chris Molloy’s career journey

03:17 From pharma to biotech and informatics

05:04 Building the Medicines Discovery Catapult

09:04 The role of the Bioindustry Association

11:25 Carrying science into leadership

13:29 Misunderstandings about UK life sciences

17:09 UK’s long-term inventiveness and ambition

19:38 The UK’s biotech superpower

22:56 UK as a global biotech hub

24:05 Why successful companies often leave the UK

28:12 Bridging science and business

32:48 What government can do for biotech

34:37 Impact of biotech on patients and society

37:46 Speeding up medicine development

40:08 Why biotech should be regionalized

45:16 Birmingham’s unique biotech opportunities

47:58 What a thriving biotech ecosystem looks like

52:24 Connecting regional clusters for growth

54:14 Vision for UK biotech in 2036

57:14 Challenges and concerns for UK biotech

01:00:13 The importance of confidence and purpose

01:04:02 The collective responsibility for biotech success

01:04:44 Final thoughts and future outlook

Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

As we get older, our immune memory wanes, leaving us vulnerable to infections. Learn why this happens and what to watch for.

Just as we experience cognitive changes with age, our aging immune system becomes less efficient at recognising pathogens. This natural decline means the body is slower to respond to threats, which significantly increases the risk of serious illness. We look at the biological reality of this process and why it makes older adults more susceptible to common infections.

Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders!

Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation.

Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now:

https://lifesciencesweek.co.uk/attend/

⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences!

Subscribe for weekly health insights, and let me know in the comments if you have questions about immune health.

0:00 The Hidden Toll of Modern Survival

0:45 Meet the Professor Behind the Lab Bench

7:20 From Medical Student to Immunology Expert

11:52 Why Survival Is No Longer Sufficient 18:17 Demystifying Secondary Immune Deficiency

31:24 The Long Road to Patient Recovery

38:30 The Unsung Hero of Modern Healthcare

52:45 The Power of Public-Private Partnerships

1:14:04 A Vision for the Future of Healthcare

In this conversation, Kaushik Trivedi interviews Professor Andrew Beggs, a pioneering figure in cancer genetics and surgery. They discuss the traditional approaches to cancer treatment and how Andrew's dual role as a surgeon and scientist allows him to bridge the gap between immediate patient care and long-term research. Andrew shares his personal journey, including moments of self-doubt, the emotional challenges of balancing surgery and research, and the sacrifices made in pursuit of excellence. The conversation also touches on the evolution of cancer understanding, the importance of collaboration in research, and the future of cancer treatment through genomics and immunotherapy. In this conversation, Andrew Beggs discusses the transformative potential of liquid biopsies, advancements in precision therapy, and the future of organoid technology in cancer treatment. He highlights the challenges in organoid culture and the revolutionary impact of long-read genomic sequencing. The discussion also covers the role of AI in cancer diagnostics, the emerging innovation hub in the West Midlands, and the barriers to biotech advancement in the UK. Finally, they touch on the significance of Life Sciences Week as a platform for fostering collaboration and innovation in the healthcare sector.

Exclusive Access: Life Sciences Week 2026 (#LSW26)!We are thrilled to announce that Drug Diaries is partnering with Life Sciences Week 2026 (21–25 September 2026), the UK’s premier gathering for biotech, pharma, med-tech, AI, and healthcare policy leaders!

Join 3,000+ industry pioneers, policymakers, and investors as we dive deep into the future of healthcare innovation.

Seats are filling fast—secure your spot today with our exclusive community discount! 🎟️ Register Now:

https://lifesciencesweek.co.uk/attend/

⚡ Exclusive Discount Code: DRUGDIARIES10 (Use at checkout for an exclusive discount!)Don't wait—claim your ticket now and be part of the national conversation shaping life sciences!

Chapters 00:00 Introduction to Andrew Beggs and his dual role in surgery and science 02:44 Andrew's motivation for combining surgery with genomics research 04:23 Early influences and the evolution of Andrew’s career 06:31 Overcoming self-doubt and career setbacks 09:48 Spark for cancer genetics and core beliefs changed 12:24 Handling emotional challenges of patient outcomes 14:29 Balancing clinical intensity with scientific research 16:01 Personal sacrifices and leadership in high-stakes environments 17:17 Lessons on leading multidisciplinary teams 21:19 Explaining cancer heterogeneity to a child 22:38 Progress in cancer genomics and immunotherapy 24:06 Liquid biopsy and its revolutionary potential 27:25 Organoids and personalized drug testing 34:48 Advances in long-read sequencing technology 37:50 AI in cancer diagnostics and research 40:48 Predicting immune responses with AI and genomics 42:22 West Midlands as a biotech innovation hub 47:43 Future of cancer treatment and diagnostic breakthroughs in 10 years Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

How one pharmaceutical development project generated 50 billion dollars despite management trying to kill it. See the high-stakes reality.

In this episode, Dr. David Brown shares his 52-year journey in drug discovery, the transformative potential of AI in medicine, and the urgent need for the pharmaceutical industry to embrace paradigm shifts to reduce human suffering.

You will hear the inside perspective of a clinical development committee meeting where the project was faced with a three-month deadline to prove efficacy or face total termination. This is for anyone interested in the friction between medical research and corporate budget constraints.

Learn how drug discovery survives when budgets are cut to zero and leadership demands immediate results. We examine the tension of professional life when your career hinges on proving the viability of a vital medical treatment. Understand the pressure of navigating complex clinical trials while your own company actively attempts to shut you down.

Subscribe for weekly career breakdowns and tell me, have you ever had to fight for a project you believed in against all odds?

Chapters

0:00 The $50 Billion Discovery That Almost Never Was

5:05 From Punch Cards to AI-Driven Medicine

9:10 Why AI Must Be the Foundation, Not a Bolt-On

14:07 The Stagnation of Big Pharma's Financial Engine

18:06 The 90-Day Thread: A Project Hanging by a Wire

25:03 The Lightbulb Moment: Connecting the Dots

35:55 Navigating Power Plays in Legacy Organizations

42:21 Mapping Mountains and Valleys with AI

Get vidIQ to grow your channel faster! 🚀

https://vidiq.com/DrugDiaries

In this episode, Kaushik Trivedi interviews Professor Neil Hanley about the transformative healthcare innovations happening in the West Midlands, UK. They explore regional collaboration, cutting-edge research, and the future of data-driven medicine.

As a thank you to the Drug Diaries Podcast community, I am pleased to share an exclusive 10% discount for Life Sciences Week 2026. Use code: DRUGDIARIES10

https://lifesciencesweek.co.uk/conference-launch-tickets/

Chapters

00:00 Introduction to the West Midlands healthcare revolution

01:19 Neil Hanley's role in shaping UK health innovation

03:10 Neil Hanley's early career and scientific inspiration

11:13 The concept of the golden parallelogram in UK science

14:41 The strategic importance of Birmingham's diverse healthcare ecosystem

20:58 The Birmingham Health Innovation Campus and its facilities

25:31 Co-locating startups, scientists, and healthcare providers

32:44 Data-driven healthcare and AI in preventative medicine

38:44 Future directions in aging, longevity, and gene therapy

48:53 Neil Hanley's legacy and vision for Birmingham

Get vidIQ to grow your channel faster! 🚀 https://vidiq.com/DrugDiaries

This discussion breaks down the current state of artificial intelligence integration within the pharmaceutical sector. We examine why scaling AI solutions is a major hurdle for many organisations and how to overcome the gap between technical capability and actual deployment. This is essential viewing for anyone trying to navigate the complexities of adopting advanced technologies in a highly regulated environment.

If you are a vendor selling to pharma, the advice provided here is critical. We discuss why generic pitches fail and why presenting concrete AI business cases is the only way to secure buy-in from stakeholders. Instead of focusing on hype, learn how to demonstrate measurable ROI and operational efficiency to decision-makers who need to see real-world results before committing to new partnerships.

Subscribe for weekly B2B strategy breakdowns, and comment below on which industry sector you want us to analyse next.

Chapters

00:00 Introduction to AI's role in healthcare decision-making

02:28 Flora Eduard's background and industry transformation

06:40 The surprising lack of data use in pharma decision-making

08:11 Leadership principles Flora refuses to compromise

12:45 Cultural insights from working across countries

16:08 Biggest setbacks and lessons learned

22:39 Digital transformation vs. digitization

28:41 Current state of AI experimentation in pharma

31:52 Understanding agentic AI and its differences from traditional AI

34:45 The future of AI and how soon it will arrive

40:49 AI's potential to improve patient outcomes

45:33 Skills needed for future leaders in the AI era

01:10:10 The future of pharma in 2035

01:11:48 Rapid fire insights and predictions

Get vidIQ to grow your channel faster! 🚀https://vidiq.com/DrugDiaries Learn how to approach AI in pharma by focusing on proven business cases rather than theoretical potential. Discover what works today.

Stop sending mass emails that land you on a blacklist. Learn why mass email practices hurt healthcare communication and how Maya offers a better way.

Sending unsolicited bulk emails to entire departments is a fast way to get your domain blocked. This video explains the mechanics behind vendor blacklisting and why standard mass outreach strategies often fail in clinical environments. If you are struggling with low engagement or deliverability issues, understanding these risks is the first step toward fixing your outreach.

We discuss the concept of Maya as a potential path forward. The core takeaway is that even the most advanced technical solutions fail if they do not fit the specific communication landscape of healthcare. We analyze why context and recipient relevance matter more than volume when you are trying to reach busy medical professionals.

Subscribe for weekly email deliverability breakdowns, and comment below if you have ever faced a domain blacklist issue.

keywords

healthcare innovation, pharma digital transformation, content experience, AI in pharma, networking, pilot projects, healthcare technology

key topics

The importance of authentic human connection in healthcare Challenges and opportunities in pharma digital transformation The future of AI and agentic technology in healthcare Effective networking and relationship building in pharma Scaling pilots and proof of concepts for long-term success

guest name: Gaurav Sanganee

Chapters

00:00 The Crisis in Healthcare Communication

02:59 Breaking Away from Convention

05:25 The Role of Closing Delta and Relato

08:12 Navigating the Challenges of Pilots and Proof of Concepts

10:46 The Importance of Incremental Change

13:09 The Static Content Crisis in Pharma

15:41 The Future of Healthcare Communication

31:06 The Evolution of Content Delivery

35:44 Transforming Scientific Content Presentation

41:02 Embracing New Technologies in Pharma

47:30 The Future of Healthcare Tech

52:46 Rapid Fire Insights and Reflections

Resources

Founder - The MacDonald Story - https://www.imdb.com/title/tt0107048/

Maverick - https://www.imdb.com/title/tt1631867/

Relayto Content Experience Platform - https://relayto.com/

Closing Delta - https://www.linkedin.com/company/closing-delta/about/

Guest links

LinkedIn: https://www.linkedin.com/in/gaurav-sanganee/

Get vidIQ to grow your channel faster! 🚀

https://vidiq.com/DrugDiaries

In this conversation, Kaushik Trivedi speaks with Jennifer Kane Burk Mosa, who has navigated a diverse career as a diplomat, healthcare executive, entrepreneur, and comedian. They explore the themes of curiosity, impact, and the importance of understanding human behavior in various sectors, particularly healthcare. Jennifer emphasizes the need for collaboration and listening to patients to create meaningful solutions in healthcare systems. The discussion also touches on the challenges of transitioning from public to private healthcare and the complexities of global health initiatives. In this conversation, Jennifer Cain Birkose discusses the importance of understanding patient interactions with technology and the role of ethnography in pharmaceutical development. She highlights the mission of Viva Valley in supporting older adults to live independently and delves into the implications of the MFN policy on drug pricing and access. Additionally, she explains the critical role of market access professionals in navigating the complexities of the pharmaceutical industry and provides insights into a typical day in their lives. In this conversation, Jennifer Cain Birkose and Kaushik Trivedi explore the critical role of patient involvement in healthcare, the definition of independence for older adults, and the importance of quality of life over mere longevity. They discuss the lessons learned from older generations, the surprising journey into comedy, and how improv can serve as a valuable tool for leadership. The conversation also touches on the connection between laughter and trust, the embrace of nonlinear career paths, and the transformative power of the phrase 'Yes, And' in both personal and professional contexts.

Chapters

00:00 The Courage to Become Many Things

02:16 Curiosity and Impact: A Life of Many Roles

06:50 The Thread of Impact in Healthcare and Beyond

11:27 Diplomacy and Human Behavior: Understanding Incentives

13:53 Transitioning from Public to Private Healthcare

20:50 Global Health Initiatives: Collaboration is Key

24:24 Listening to Patients: The Missing Voice in Healthcare

27:36 Understanding Patient Interactions with Technology

30:30 The Role of Ethnography in Pharma Development

31:45 Viva Valley: Supporting Independent Living for Older Adults

33:14 Exploring the MFN Policy and Its Implications

45:04 The Role of Market Access Professionals in Pharma

55:35 A Day in the Life of a Market Access Professional

57:53 The Importance of Patient Involvement

01:01:14 Defining Independence for Older Adults

01:04:30 Quality of Life vs. Length of Life

01:08:31 Lessons from Older Generations

01:10:23 The Surprising Journey into Comedy

01:13:10 Improv as a Leadership Tool

01:17:27 The Connection Between Laughter and Trust

01:22:04 Embracing Nonlinear Career Paths

01:23:58 The Power of 'Yes, And'

Guest LinkedIn: https://protect.checkpoint.com/v2/r01/___https://www.linkedin.com/in/jennifer-cain-birkmose-ab05a6?utm_source=share_via&utm_content=profile&utm_medium=member_ios___.YzJ1OmFlc2FyYTE6YzpvOjQ2ZWVmZGEzMDY0YTU1OTlkYTFkZjVjM2YyMzQ5NWZjOjc6YzBmNDpiYjVhZjU0NGIxZTRkYThmMTkxYzU2NWYyNmZiMGM4YjQzMDAzNTU1YjNkZTFiOTFhZjY1MTJkNDQ5ZjIwYWFkOmg6VDpG

Aesara: www.aesara.com

MMV: https://www.mmv.org/

Vivavalet: www.vivavalet.com

Ted talks https://www.ted.com/search?q=jennifer%20cain%20birkmose INC article reference: https://www.inc.com/suzanne-lucas/look-for-these-5-traits-to-find-your-high-potential-employees/91198182

Explore the fascinating science of skin biology with Benjamin Fuchs, a skincare expert with over 45 years of experience. Discover how internal health, nutrition, and cellular processes influence skin aging, acne, and overall skin health. In this episode, Benjamin Fuchs discusses the science behind skin health, debunks common skincare myths, and shares practical advice on how to support skin from the inside out. Discover how internal nutrition, proper skincare ingredients, and understanding skin signals can transform your approach to skin health.

keywords skin biology, skincare science, collagen, hydration, aging, cellular health, skin care tips, Benjamin Fuchs skin health, skincare myths, internal nutrition, acne treatment, skincare ingredients, dermatology, skin aging, topical nutrients, skincare tips, health and wellness

takeaways Skin is a living, breathing biochemical organ, not just a surface. Supporting internal health and blood circulation is key to skin health. Most skincare products disrupt the skin's electrical and biological processes. Exfoliation and supporting natural cell turnover strengthen skin. Structured water and supporting collagen production are vital for hydration.

guest name

Benjamin Fuchs

Chapters

00:00 Understanding Skin: The Overlooked Organ

02:56 The Science of Skin: Beyond Surface Level

05:58 The Bioelectrical Nature of Skin

08:48 Skin Structure: Layers and Functions

12:04 The Journey of Skin Cells

14:53 Hydration vs. Moisturization: The Real Difference

18:02 The Role of Blood in Skin Health

20:57 Topical Solutions: What Really Works?

24:11 Exfoliation: The Key to Healthy Skin

34:59 The Science of Exfoliation

38:20 Understanding Structured Water

43:58 The Role of Collagen in Aging

48:44 Factors Contributing to Collagen Decline

52:59 Why Does Skin Age? 55:25 The Impact of Skin Tone on Aging

56:42 Acne: Understanding True vs Faux

01:08:05 Skincare Strategies for Teenagers

01:13:34 The Dangers of Benzoyl Peroxide

01:16:05 The Superiority of Salicylic Acid

01:18:38 The Importance of Active Ingredients

01:20:50 Nutritional Foundations for Skin Health

01:24:41 Understanding Skincare Labels

01:25:35 Key Principles for Skin Health

01:26:14 Rapid Fire Myths and Facts

01:31:17 Debunking Skincare Trends

01:35:59 The Truth About Moisturizers

01:37:27 Final Thoughts on Skin Health

Resources Benjamin Fuchs' Website Vitamin A Supplements Zinc for Skin Health Selenium Supplements Salicylic Acid Topical Treatments Chemical Sunscreens and Alternatives Topical Nutrients for Skin

Liz Parrish shares her groundbreaking journey into gene therapy, her motivations driven by her son's diagnosis, and her vision for a future where aging and disease are conquerable. This conversation explores the science, ethics, and future of longevity research, emphasizing the importance of innovation and human rights in healthcare.

Chapters

00:00 Introduction and Liz Parrish's Background

02:49 Liz Parrish's First Human Gene Therapy Experience

03:39 Parenting a Child with Type 1 Diabetes

05:23 Children's Hospitals and Medical Challenges

07:10 The Cost and Accessibility of Life-Saving Treatments

08:08 Hope and Grief in Medical Innovation

10:10 Realization of Unconventional Approaches

11:54 Treating Biological Aging and Childhood Diseases

13:35 Criticism of Incremental Medical Progress

15:27 Resistance to Technological Change in Medicine

16:57 The Potential of Gene Therapy for Humanity

18:59 Biohacking and Scientific Rigor

21:02 The Future of Humanity Without Aging

23:12 The Day of Her Gene Therapy Treatment

25:48 Experiences During the Treatment Process

27:23 What Was Entering Her Body

29:45 Different Gene Therapies Used

30:40 Addressing Critics and Scientific Rigor

33:41 Overcoming Media and Regulatory Challenges

37:26 Debunking Cancer and Safety Myths

47:25 The Science of Telomerase and Cancer Risks

51:21 Gene Therapy Delivery Methods and Toxicity

52:34 Animal Data vs Human Data in Longevity Research

55:11 The Biggest Lie in Longevity Industry

56:32 Misunderstandings About Telomerase Activation

58:35 Regulatory Barriers and Economics in Aging Treatments

01:01:38 Mainstream Pharma's Skepticism Toward Aging as an Indication

01:06:28 The Urgency of Access to Longevity Treatments

01:10:07 Emotional Impact of Treatment Outcomes

01:14:36 The Future of Humanity and Aging

01:16:14 What Will Kill Us in a World Without Aging

01:20:55 Simulation Theory and Reality

01:23:00 Philosophy, Spirituality, and the Nature of Existence

01:25:02 The Power of Upgrading Our Mindset

01:27:18 Closing Remarks and Future Outlook

Get vidIQ to grow your channel faster! 🚀

https://vidiq.com/DrugDiaries

In this episode, Dr Elliot Justin discusses the fascinating connection between sexual health, cardiovascular health, and why the body often provides early warning signs long before more serious health issues emerge.

If you'd like to learn more about FirmTech and the technology discussed in this conversation, you can explore it using the link below.

As a listener of Drug Diaries, you'll receive 20% off your purchase using the code DRUGDIARIES.

🔗 Affiliate Link: https://myfirmtech.com/kaushiktrivediq5

A note on transparency: FirmTech sponsored this episode and Drug Diaries may earn a commission if you choose to make a purchase through this link. This comes at no additional cost to you.

Importantly, 100% of any commissions earned from this partnership will be donated to Childhood Cancer International (CCI), a global charitable organisation that supports children with cancer and their families in low- and middle-income countries.

Thank you for supporting both the podcast and this important cause.

Chapters

00:00 Breaking the Silence on Sexual Health

02:26 Understanding the Signals of Erectile Dysfunction

04:42 The Importance of Nocturnal Erections

07:32 The Role of Wearables in Sexual Health

09:51The Psychological Barriers to Discussing Sexual Health

12:33 The Misdiagnosis of Erectile Dysfunction

14:56 The Impact of Aging on Sexual Health

17:16 The Shift in Patient Attitudes

19:39 The Legacy of Sexual Health Advocacy

21:42 The Need for Action in Sexual Health

24:14 Planning for Pleasure in Relationships

32:08 Understanding Erectile Dysfunction: The Physiological and Psychological Factors

39:32 The Role of Technology in Sexual Health

44:25 Real User Stories: Transformative Experiences with the Ring

48:47 Behavior Change and the Importance of Tracking Sexual

HealthResources

Firm Tech Wearable Devices

Childhood Cancer International

Elliot Justin's Research on Sexual Health MonitoringGuest links

LinkedInTwitterGet vidIQ to grow your channel faster! 🚀

https://vidiq.com/DrugDiaries

At 57, hear how being proactive has allowed me to delay many of the typical signs of aging. This discussion highlights the importance of a healthy lifestyle and an aging mindset to experience aging well. Learn how small, consistent choices can contribute to healthy aging and provide longevity tips for everyone.

Explore the science of aging with Dr. Sandra Kaufmann, who breaks down aging into seven biological categories and discusses actionable strategies, supplements, and lifestyle choices to slow or reverse aging processes.

Chapters

00:00 Understanding Aging: A New Perspective

02:21 The Disconnect in Medicine: A Personal Journey

05:01 The Science of Aging: Chronological vs Physiological

07:51 Breaking Down Aging: The Kaufman Protocol

10:07 The Seven Tenets of Aging

12:55 The Role of Supplements in Longevity

15:42 Exploring the First Tenet: DNA and Telomeres

18:18 Mitochondrial Health: The Second Tenet

21:57 Pathways of Aging: The Third Tenet

25:47 The Foundations of Longevity: Diet and Exercise

27:46 Personalized Health Protocols: Tailoring to Individual Needs

31:05 Understanding Oxidative Stress and Its Impact

31:17 Glycation: The Hidden Dangers of Sugar

37:52 Debunking Longevity Myths: Hyperbaric Oxygen Therapy

39:49 Metformin: A Double-Edged Sword for Longevity

41:18 The Role of Supplements: Balancing Science and Basics

45:12 Key Overlooked Factors for Longevity

46:01 The Importance of Sleep

48:01 Supplements for Better Sleep

50:09 Democratizing Longevity

51:57 Future Perspectives on Aging

53:23 Defining a Well-Lived Life

54:30 Rapid Fire on Longevity Supplements

resources

The Kaufman Protocol - https://www.kaufmanprotocol.com

Sandra Kaufmann's Website - https://www.kaufmanprotocol.com

Metformin - https://en.wikipedia.org/wiki/Metformin

Resveratrol and Pterostilbene - https://en.wikipedia.org/wiki/Resveratrol

NMN and NR supplements - https://en.wikipedia.org/wiki/Nicotinamide_mono nucleotide

Exosome Therapy - https://www.exosome.com

Connect with

Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/

This video takes a thought-provoking journey into the fundamental question of why we age, exploring the intricate mechanisms of human biology. It delves into the concept of "biological age" and even presents a unique perspective on "cancer research" and its potential role in "evolution". The discussion also touches upon personal reflections on "mortality", prompting us to consider how to live longer.

Kaushik Trivedi interviews Dr. Bill Andrews, a pioneer in genetics and telomere research, about the science of aging, telomerase, and the obstacles to curing aging. They explore the biological mechanisms behind aging, the history of telomere research, and the societal challenges in achieving longevity breakthroughs. In this in-depth interview, Bill Andrews shares his pioneering work in telomere research, anti-aging therapies, and the future of human longevity. Discover how scientific breakthroughs, strategic funding, and personal discipline are shaping the quest to extend healthy lifespan beyond natural limits.

keywords

aging, telomeres, telomerase, genetics, longevity, biotech, science of aging, Dr. Bill Andrews, anti-aging research, biotech obstacles telomeres, anti-aging, longevity, scientific research, human lifespan, telomerase, aging therapies, biotech innovation, health optimization, future of medicine

Chapters

0:00:00 – 0:01:47 Trailer

0:01:47 – 0:03:27 Introduction

0:03:27 – 0:04:32 Why Bill is doing this interview

0:04:32 – 0:23:25 Bill’s background

0:23:25 – 0:28:40 Telomere Biology and Aging

0:28:40 – 0:30:20 Telomerase does not cause cancer

0:30:20 – 0:41:05 Evolution of Aging and other diseases

0:41:05 – 0:45:55 Causes of Aging

0:45:55 – 0:47:12 Why cure aging

0:47:12 – 0:54:53 More on Causes of Aging and Evolution

0:54:53 – 1:13:07 Obstacles to Curing Diseases and the Solutions.

1:13:07 – 1:28:30 How Bill Will Cure Aging

1:28:30 – 1:33:24 Bill’s Research at Sierra Sciences Up to Now.

1:33:24 – 1:36:06 More on Telomere Biology and Aging

1:36:06 – 1:41:38 Searching for Nutraceutical Telomerase Inducers

1:41:38 – 1:44:45 Touchstone Essentials and Telo-Vital

1:44:45 – 1:56:08 Telomere Length and Almost All Diseases

1:56:08 – 2:02:02 Should Aging NOT be Cured?

2:02:02 – 2:22:03 Bill’s Personal Longevity Practices

2:22:03 – 2:23:15 Bill’s Prediction of What Life Will be Like in 30 Years.

2:23:15 – 2:26:36 Longevity and Religion

Resources

The Immortalists (Documentary)

Kaushik Trivedi's Website

Dr. Bill Andrews' Research Lab

Sierra Sciences

Betty White

Caldwell Esselstyn's book 'The Prevent and Reverse Heart Disease'

Touchstone Essentials TeloVital

Kaufman Protocols by Dr. Sandra Kaufman

Aubrey de Grey's work on aging

Guest

links

Twitter

LinkedIn

Website

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with

Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/

Our latest segment introduces "Drug Diaries Den," a platform designed for innovators to present scientific ideas, aiming to accelerate **drug development**. Dr. Subhadra David showcases an innovative AI-enabled digital animal replacement technology, addressing the high failure rates in human clinical trials and improving **drug discovery**. This technology leverages **artificial intelligence** and human microphysiological platforms to enhance **clinical research** and advance **innovation in healthcare** by reducing reliance on traditional **animal research**.

This episode features a panel discussion on innovative approaches in drug development, focusing on AI-enabled human microphysiological systems as a replacement for animal testing. Experts share insights on scientific validation, translational feasibility, and the future of ethical, faster, and more accurate drug discovery.

Chapters

00:00 Introduction to Drug Diaries Den

02:01 Panel Introduction and Expertise

06:04 Presentation of Innovation by Dr. Subhadra Dhavit

16:54 Discussion and Panel Insights

17:20 The Potential of New Approaches in Drug Development

19:18 Challenges in Evaluating New Drug Modalities

20:20 Feedback and Insights on Drug Development Strategies

23:43 Regulatory Considerations and Validation in Drug Development

28:16 Exploring the Limits of New Technologies

31:30 Evaluating the Platform from a Venture Perspective

35:11 Commercial Opportunities and Challenges in Drug Development

39:55 Assessing Innovation in Biotechnology

44:29 Final Thoughts and Reflections on the Discussion

Eesources

Transcel Biologics

American Association for Precision Medicine

Genentech Roche

Rutgers University

Wise Capitals

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with

Kaushik Trivedi (Host) - https://www.instagram.com/drugdiaries_/

S. Dravida - https://www.linkedin.com/in/s-dravida-she-her-65011611/

Debraj Dasgupta - https://www.linkedin.com/in/debrajdasgupta/

Paul Agapow - https://www.linkedin.com/in/paul-agapow/

Sadanand Vadola - https://www.linkedin.com/in/sadanand-vodala-305b022a/

Dr. Prasun Mishra - https://www.linkedin.com/in/prasunjmishra/

Despite advancements in healthcare technology, the patient care experience often feels fragmented. This video highlights the disconnect between sophisticated medical innovations, like artificial intelligence for early disease detection, and the actual human connection patients receive. We explore how even with cutting-edge technology, the healthcare industry struggles to provide a truly integrated and empathetic experience for individuals.

Dr. Fatih Mehmet GUL shares insights on the evolution of healthcare, digital transformation, connected care, AI, and future trends. Discover how technology, human touch, and system re-engineering can create healthier communities and improve patient outcomes.

Chapters

00:00 The State of Healthcare Innovation

02:49 Defining Moments in Healthcare Leadership

05:44 Integrating Technology with Human Empathy

08:23 The Importance of Connected Care

11:21 Transforming Patient Experience

14:10 The Role of Caregivers in Healthcare

16:59 Re-engineering Healthcare Systems

20:11 The Next Generation of Patients

23:07 The Need for Continuous Patient Engagement

25:54 The Crisis of Healthcare Professionals

28:52 The Coexistence of Technology and Humanity

31:45 Rethinking Healthcare Operations

34:35 The True State of Global Healthcare

39:40 Navigating Healthcare Complexity

43:46 The Role of AI in Healthcare

48:38 AI Successes and Failures

53:25 Patient Experience and Technology

57:45 Challenges in Healthcare Innovation

01:01:58 Global Influences on Healthcare

01:03:13 Future of Healthcare: A Decade Ahead

01:07:55 Longevity and Healthy Aging

01:12:02 Myths vs. Realities in Healthcare

01:14:11 Confronting Healthcare Realities

Resources

Connected Care

Framework AI Governance in Healthcare

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Is obesity a failure of the individual, or a chronic disease shaped by biology, environment, psychology, and systems? This video explores the complexities of obesity treatment, questioning whether it's an individual's fault or a deeper issue. We discuss how lifestyle medicine and understanding insulin resistance are crucial in effective weight management, moving beyond simple solutions.

Kaushik Trivedi hosts Sarah Le Brocq to explore the complex realities of obesity, emphasizing lived experience, science, policy, and systemic change. This conversation challenges oversimplified narratives and advocates for compassionate, evidence-based approaches.

Obesity, lived experience, healthcare policy, stigma, treatment, systemic change, mental health, medical innovation, advocacy

Chapters

00:00 Rethinking Obesity: A New Narrative

01:52 The Human Experience Behind Obesity

11:17 The Complexity of Obesity: Beyond Willpower

17:45 Stigma and Its Impact on Healthcare

22:27 From Personal Journey to Advocacy

25:44 Integrating Lived Experience in Healthcare Advocacy

27:12 Authenticity in Storytelling

28:45 The Bigger Picture in Advocacy

30:25 The Importance of Patient Voices

32:08 Current Trends in Obesity Care

37:44 Access to Innovative Treatments

38:39 Defining Obesity: A Complex Issue

43:24 Challenges in NHS Prescriptions

45:51 The Role of Pharmaceutical Companies

49:07 Envisioning Future Obesity Care

51:28 Personal Reflections on Resilience

55:04 A Message to Those Living with Obesity

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

keywords healthspan, functionality, aging, wellness, resilience, health metrics, functional capacity, dual task training, empowerment, social health

takeaways Health span is determined by how we function, not just lab results. Functional blindness refers to being unaware of our physical capabilities. Our weakest link in health can determine our overall health span. Fitness does not equate to resilience; balance is crucial. Functional metrics can predict health span better than disease indicators. The five domains of function are strength, cardiovascular health, mobility, structure, and cognition. Simple tests can assess functional capacity at home. Dual task training enhances brain function and resilience. Awareness of functional capacity empowers individuals to take action. Social engagement can enhance the experience of improving health span.

summary In this conversation, Prof. Scott Fulton discusses the concept of healthspan, emphasizing the importance of functionality over traditional health metrics. He introduces the idea of functional blindness, where individuals are unaware of their physical capabilities, and explains how our weakest link can determine overall health. Fulton outlines the five domains of function—strength, cardiovascular health, mobility, structure, and cognition—and provides practical assessments for individuals to gauge their functional capacity. He highlights the significance of dual task training for brain health and the empowering nature of awareness in shaping one's aging experience. The discussion concludes with a focus on the social aspects of functionality and the importance of community in enhancing healthspan.

Chapters

00:00 Understanding Health Span vs. Disease

03:12 The Concept of Functional Blindness

06:19 The Weakest Link in Health Span

09:20 Function as a Predictor of Health Span

14:15 The Five Domains of Function

18:57 Understanding VO2 Max

20:10 Simple Tests for Functional Assessment

25:23 Empowering Daily Life Choices

26:41 The Blue Zones and Functional Living

28:28 Defining Functional Age

28:52 Understanding Functional Ability Across Ages

31:17 The Shift from Reactive to Preventive Medicine

34:30 The Importance of Dual Task Training

43:54 Discovering Functional Blind Spots

47:54 Empowerment Through Awareness and Agency

51:27 The Social Aspect of Function and Healthspan

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Our latest discussion explores the universal desire for a healthy, long life, emphasizing that aging is a primary driver of disease. We consider various approaches to healthy ageing and the pursuit of a longer healthspan. While true solutions for how to live longer currently favor the wealthy, understanding aging biology and metabolic health are crucial for disease prevention. This episode prompts us to rethink access to longevity solutions for everyone.

In this conversation, Kaushik Trivedi and Dylan Livingston explore the implications of aging as a treatable condition rather than an inevitable decline. They discuss the role of policy in shaping longevity research, the need for societal acceptance of aging interventions, and the potential economic benefits of extending healthy lifespans. The conversation also touches on the risks associated with longevity breakthroughs and the importance of making these advancements accessible to all. Ultimately, they emphasize the need for a shift in healthcare from reactive to proactive measures, highlighting the societal changes that could arise from longer, healthier lives.

Chapters

00:00 The Uncomfortable Truth About Aging

01:26 The Disruption of Aging Policy

03:11 Dylan's Journey into Longevity Advocacy

08:44 Bridging Science and Policy

10:24 The Need for Diverse Voices in Longevity

12:12 Inspiration from Pioneers in the Field

13:04 The Unconventional Path to Advocacy

15:16 Curiosity Over Skepticism in Policy Discussions

19:18 Bipartisan Support for Longevity Initiatives

24:34 Aging 1.0 vs. Aging 2.0

27:07 The Economic Impact of Healthy Aging

30:11 Making Longevity Accessible to All

32:41 The Role of Government in Longevity Drug Accessibility

34:08 Awareness and Misconceptions in Longevity

36:51 Realism vs. Hype in Longevity Innovations

39:25 Mainstreaming Longevity Medicine

43:42 Government's Role in Longevity Interventions

47:35 Societal Changes with Extended Lifespan

53:09 The Future of Work and Leisure in an AI-Driven World

54:07 Potential Risks of Extended Lifespan

56:21 Hope and Challenges in Longevity Advocacy

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

In this conversation, Kaushik Trivedi and Debraj Dasgupta explore the evolving landscape of careers, leadership, and the importance of human connection in a rapidly changing world. They discuss the challenges of digital transformation, the need for a cultural shift in organizations, and the significance of building communities. Debraj shares his personal journey from corporate life to entrepreneurship, emphasizing the importance of redefining success and fulfillment. The conversation highlights the necessity of human relationships in an age dominated by technology and AI, and the responsibility of leaders to invest in the next generation.

Takeaways Most careers stall rather than end, leading to a crisis of meaning. Digital transformation fails when organizational culture does not evolve. Networking should focus on building trust rather than just contacts. Success and fulfillment can diverge in one's career journey. Reinvention requires courage and a willingness to embrace uncertainty. Human connection becomes more valuable as technology advances. The future of work will involve collaboration between humans and AI. Companies must adapt to retain talent by fostering a supportive culture. Building communities is essential in the digital age. Leaders have a responsibility to mentor and support the next generation.

Chapters

00:00 The Crossroads of Career and Meaning

02:13 Navigating Career Phases and Personal Growth

04:55 Redefining Success and Fulfillment

07:35 The Courage to Reinvent

09:58 Building Digital Culture vs. Digital Projects

12:23 The Myths of Digital Transformation

14:53 Future-Ready Talent and Retention Challenges

19:43 Navigating the Future of Work

22:03 Identity and Career Transitions

24:19 The Art of Networking

26:53 Building Communities in a Digital Age

29:12 AI's Role in Leadership

31:30 The Leadership Vacuum and Next Generation

32:57 The Responsibility of Experienced Leaders

34:28 The Importance of Human Connection

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

In this enlightening conversation, Kaushik Trivedi speaks with Sophia Lugo, CEO of Radar Therapeutics, about the transformative potential of programmable genetic medicines. They explore the limitations of current mRNA therapies, the importance of precision over power in medicine, and the ethical implications of innovation in healthcare. Sophia shares her personal journey, the challenges of building a biotech company, and the need for public trust in genetic medicine. This discussion highlights the future of medicine as not just more advanced, but more intentional and responsible.

The biggest problem in modern medicine may be the bluntness of drugs. Medicines should not only act but also decide when and where to work. Sophia Lugo is driven by a desire for justice and equal access to technology. Personal responsibility and hard work are key to success. mRNA therapies have not yet achieved therapeutic approval, only vaccines. Precision in medicine is becoming more important than raw power. Programmable medicines could fundamentally change drug development. Public trust in genetic medicine involves emotional and ethical considerations. The human aspect of building a biotech company is often more challenging than the science. The future of medicine will be more intentional, focusing on the impact on humanity.

00:00 The Evolution of Medicine: From Power to Precision

11:11 The Limitations of Current Genetic Therapies

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

In this conversation, Kaushik Trivedi speaks with Dr. Reinhard Berkels,, a seasoned leader in medical affairs, about the critical role of medical affairs in the pharmaceutical industry. They discuss the navigation system that medical affairs provides for drug launches, the importance of real-world evidence, and the evolving role of MSLs. Dr. Berkels shares insights from his extensive experience, emphasizing the need for collaboration, empathy, and effective communication in medical affairs. The conversation also touches on the impact of digital transformation and the importance of understanding cultural differences in global medical affairs.

Chapters

00:00 Navigating the Complex World of Medical Affairs

02:00 The Journey into Medical Affairs

11:48 Understanding the Role of Medical Affairs

14:09 First Impressions in Medical Affairs

15:42 Myths and Misconceptions about Medical Affairs

17:21 Cultural Differences in Medical Affairs

19:18 The Role of MSLs in Clinical Trials

24:49 Redefining the MSL Role for Today

28:02 Challenges in Deploying MSLs Early

32:40 Post-Pandemic Changes in Engagement

36:25 The Omnichannel Approach in Medical Affairs

39:39 Digital Transformation in Medical Affairs

40:08 Harnessing AI in Medical Affairs

43:04 Transformative Power of AI in Research

48:03 The Role of Medical Affairs in Drug Launches

51:52 Collaboration and Communication in Medical Affairs

56:12 Real-World Evidence and Its Impact

01:00:01 Core Values and Leadership in Medical Affairs

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Linkedin: https://www.linkedin.com/in/kaushiktrivedi/

In this conversation, Gavin shares his journey from a young boy in South Wales to a senior leader in the pharmaceutical industry. He reflects on the pivotal experiences that shaped his leadership style, emphasizing the importance of personal stories, transparency, and the balance between affordability and innovation in healthcare. Gavin discusses the evolving role of market access professionals and the impact of recent policy changes on the industry. He concludes with thoughts on legacy, the importance of creating a safe environment for open dialogue, and the need for leaders to be authentic and vulnerable.

Chapters

00:00 The Hidden Decisions in Healthcare

02:11 Gavin Lewis: A Journey Through Healthcare Leadership

04:47 Formative Experiences: From South Wales to Economics

07:21 Values and Beliefs in Leadership

09:58 Navigating Moral Stress in Healthcare Decisions

12:09 Leading Through Ambiguity and Uncertainty

14:51 Balancing Affordability, Sustainability, and Innovation

17:02 The Superpower of Access Professionals

19:25 Moments of Transformation in Leadership

21:44 The Importance of Storytelling in Economics

22:51 Unlearning for Growth: Speed and Simplicity

28:02 Reprogramming Decision-Making Styles

29:03 The Future of Market Access in Healthcare

32:13 Emerging Trends in Healthcare Financing

35:53 Legacy and Leadership in Healthcare

39:15 Creating a Safe Environment for Team Dynamics

42:57 The Unique Superpower of Market Access Professionals

45:10 Understanding Introversion in Leadership

50:12 The Importance of Trusting Your Instincts

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Linkedin: https://www.linkedin.com/in/kaushiktrivedi/

In this episode of Drug Diaries, Kaushik Trivedi and Isabelle Verniers delve into the complexities of talent development in the life sciences sector. They discuss the importance of nurturing talent beyond traditional qualifications, the invisible friction points that hinder development, and the balance between internal and external talent acquisition. The conversation also highlights practical tools for fostering talent and the competencies needed for future success in a rapidly evolving industry. In this conversation, Isabel and Kaushik delve into the importance of redefining soft skills as 'impact skills' that drive real change in organizations. They discuss the significance of structured talent development programs through case studies, emphasizing the need for a clear purpose, people engagement, and proficiency in fostering innovation. Isabel shares actionable steps for organizations to cultivate an innovation-ready culture, highlighting the value of starting small and learning from pilot programs. The discussion also touches on recommended readings that can enhance personal and professional growth, reinforcing the idea that transformation begins with individuals.

Talent is a combination of knowledge, skills, and attitude. Organizations have a responsibility to develop and nurture talent. Talent can be shaped and grown through the right environment. Purpose, people, and proficiency are essential for effective talent development. External hires are often seen as more innovative due to biases. Tools and templates facilitate consistent learning and development. Curiosity and adaptability are crucial for future competencies. Collaboration across functions is vital in life sciences. Engagement and motivation are key to successful talent development programs. Human skills, or 'impact skills', are increasingly important. The term 'soft skills' can undermine their importance; they should be called 'impact skills'. Impact skills are essential for mobilizing teams and driving results. Structured talent development programs can lead to significant organizational transformation. Consistency in talent development initiatives is crucial for long-term success. Cultural change requires clear purpose, engagement, and competency alignment. Starting small with pilot programs can effectively initiate change in legacy organizations. Reflection and self-assessment are key to understanding organizational readiness for innovation. Sharing successes within teams fosters motivation and a culture of learning. Books like 'Surrounded by Idiots' and 'Atomic Habits' provide valuable insights for personal growth. Organizations thrive when they invest in their people and create supportive environments.

Sound bites

"You can shape and nurture talent."

"Talent isn't a rare gift reserved for a few."

"Purpose, people, and proficiency are key."

"Engagement is key to talent development."

"Curiosity is crucial for talent development."

"Collaboration is vital in life sciences."

"Human skills are more important than ever."

"I don't like the term soft skills."

"You need to make clear choices."

"Start small, feel."

"It's all about getting stuff done."

"Look in the mirror."

Chapters

00:00 Understanding Talent in Life Sciences

09:18 Invisible Friction Points in Talent Development

14:30 Internal vs. External Talent Acquisition

18:02 Practical Tools for Talent Development

29:27 Future Competencies for Life Sciences

32:46 Rethinking Soft Skills: The Impact Skills Perspective

36:04 Case Studies in Talent Development: Success and Lessons Learned

42:08 Resetting Culture: The Three P's Approach

45:33 Starting Small: Piloting Change in Legacy Organizations

50:14 Actionable Steps for Innovation-Ready Culture

53:00 Recommended Reads: Books for Personal and Professional Growth

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Linkedin: https://www.linkedin.com/in/kaushiktrivedi/

In this conversation, Chema and Kaushik explore the evolving landscape of the pharmaceutical industry, emphasizing the importance of patient-centric approaches and the integration of technology in enhancing patient experiences. They discuss the challenges faced by the industry, the need for empathy, and the significance of understanding patient behavior. Personal anecdotes highlight the impact of their work, showcasing the human side of healthcare and the potential of digital therapeutics to transform patient engagement.

Takeaways -

The pharmaceutical industry is undergoing significant changes, requiring a shift towards patient-centric approaches.

Empathy is crucial in understanding and addressing patient needs in healthcare.

Technology plays a vital role in enhancing patient experiences and engagement.

Personal stories can illustrate the real impact of pharmaceutical work on patients' lives.

Understanding patient behavior is essential for effective communication and engagement strategies.

Digital therapeutics (DTx) have the potential to revolutionize patient care and information access.

The industry must move beyond traditional metrics to measure success in patient engagement.

Collaboration with health patients is necessary for meaningful change in the industry.

There is a need to break down assumptions about patient behavior based on demographics.

The future of healthcare lies in understanding and responding to individual patient needs.

If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.

Connect with José Ma. (Chema) Guido Avila:

LinkedIn: https://www.linkedin.com/in/josemariaguido/

Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Linkedin: https://www.linkedin.com/in/kaushiktrivedi/

The video explores how artificial intelligence is transforming healthcare, with AI handling routine tasks to let humans focus on more critical work. This shift highlights the powerful synergy between technology and human expertise, driving significant healthcare innovation. Over 65% of pharma leaders report AI influencing real-time decisions, showcasing its impact on patient outcomes. The future of AI in healthcare emphasizes coordinated teamwork for better patient care. Chapters 00:00 – The Future of AI + Human Healthcare 01:18 – What Will AI Really Change? Hype vs Reality 02:08 – Welcome to Drug Daddies 02:29 – A Heartfelt Message: 93% Haven’t Subscribed 03:15 – Healthcare’s Silent AI Revolution 04:18 – AI Has Already Changed Healthcare 04:52 – Guest Introduction: Mohammed Haq, Cognizant 05:39 – Mohammed’s Journey + 30 Years of Experience 06:32 – The Perception Gap: People Think AI Is Future, Not Present 07:04 – The Biggest Misunderstanding About AI 08:49 – Fear of AI Replacing Jobs vs Reality of Augmentation 09:36 – Why AI Doesn’t Replace Clinicians 10:03 – The Power of Human + AI Teamwork 10:32 – The Moment AI Proved Itself: AlphaFold Breakthrough 11:28 – What’s Actually Real Today vs Still Hype 12:48 – The 6-Step Framework to Separate Signal from Noise 13:36 – Outcomes Matter: How to Evaluate AI Claims 15:15 – Winners Ask: Does AI Make Us Faster, Smarter, More Human? 15:40 – Where AI Is Saving Time, Money, and Lives 16:09 – Cognizant’s 3-Vector AI Strategy Explained 17:51 – Where AI Delivers the Most Value Across Pharma 18:17 – Using All 3 Vectors: What Clients Are Doing Today 19:29 – Agentic AI: How Mature Are These Technologies? 20:24 – Partnerships with NVIDIA, Microsoft, Google 21:53 – Why Ecosystems Win: AI at Global Scale 22:20 – What Patients Really Think About AI 23:46 – From Output to Action: The Rise of AI Agents 24:17 – Next 24 Months: Where AI Will Reshape Pharma 25:56 – The Real Barriers: Not Technology, Mindset 26:43 – BlueBolt: 53,000 People Building 30,000 AI Prototypes 28:09 – Culture Shift: Curiosity, Safety, and Innovation 28:37 – Which AI Use Cases Are Boardroom-Ready 29:30 – Clients Now Want Outcomes, Not Pilots 31:18 – The Market Is Changing Faster Than Ever 31:40 – Culture Eats Tech for Breakfast 32:38 – Democratizing Innovation at Cognizant 33:02 – How Leaders Build Safe + Ambitious AI Teams 33:37 – Predicting the Biggest Breakthrough in 2 Years 34:54 – The Excitement and Risks of AI in Healthcare 36:09 – AI: The New Electricity of Business 37:02 – Final Reflections: AI Completes Human Empathy 37:27 – Inspiring Close: AI Will Amplify the Human Heartbeat

The discussion highlights how "most favored nation" policies have evolved from theoretical policy discussions into tangible business challenges. This shift significantly impacts the "pharmaceutical industry", particularly concerning global strategies and "regulatory compliance". The conversation also delves into the implications of these policies, including the introduction of "tariffs", on international business practices. Chapters 00:00 – The Moment MFN Became Real A senior pharma leader’s launch dilemma turns MFN from theory into a business-critical threat. 02:50 – What Is MFN, Really? (Explained Simply) Chris breaks down MFN in plain language—and why it is not global price harmonisation. 05:00 – Explaining MFN to a 12-Year-Old Simple analogies that cut through the policy complexity. 07:30 – What Problem Is MFN Trying to Solve? Is MFN about affordability, fairness, leverage—or something else entirely? 10:00 – Will MFN Actually Lower Patient Out-of-Pocket Costs? Separating political rhetoric from real patient impact. 12:15 – MFN vs Recent ‘MFN-Like’ Pharma Deals Why recent Pfizer, AstraZeneca, and EMD agreements are not true MFN—and why that matters. 15:15 – Does MFN Reduce Prices or Just Shift Who Pays? Who really benefits: patients, governments, or budgets? 18:15 – “Europe Becomes a Risk, Not a Launch Anchor” Why global launch sequencing is being fundamentally rethought. 20:30 – The Global Ripple Effect: Who Feels MFN First? Which countries are most exposed—and why affordability has limits. 23:45 – MFN and R&D: What Innovation Gets Funded Next? How MFN could quietly reshape drug development priorities. 27:00 – Launch Sequencing, Evidence Strategy & Uncertainty Why companies must plan multiple launch paths simultaneously. 29:30 – Will MFN Spill Into Commercial Pricing? How Medicare and Medicaid policies may reshape the entire US market. 32:00 – Value-Based Pricing in an MFN World Why MFN complicates outcomes-based and value-based contracts. 34:30 – Confidential Discounts Under Threat Could MFN break the global confidential contracting model? 37:15 – Why Value Means Different Things in Different Countries How HTA frameworks, PICO, and comparators collide under price referencing. 40:00 – Could the World Move Toward Standardised Drug Pricing? The iPhone analogy—and why drugs are different. 42:40 – Extreme but Plausible MFN Scenarios (US Perspective) What “MFN-light” vs “MFN-heavy” futures could look like. 45:00 – Extreme but Plausible MFN Scenarios (Global Perspective) Where affordability breaks—and access risks emerge. 47:30 – The One Thing CEOs Should Do Now Scenario planning, signposts, and future-proofing launch strategy. 50:30 – Final Takeaways: MFN Is Not a Policy to Watch—It’s a Shift to Prepare For Why waiting is the biggest risk of all.

In this conversation Marek Rombel explains the importance of translating complex strategies into actionable steps for execution, emphasizing the role of cross-functional teams in ensuring clarity and effectiveness in product launches. takeaways A third of products launched are unsuccessful. Translating data and strategy is crucial for execution. Complex strategies can confuse customers if not simplified. Cross-functional teams are essential for distilling strategy. Effective execution requires clarity and simplicity. Being a great strategist also means being a great executionalist. Execution involves taking complex ideas and making them accessible. Customer confusion can stem from overly complex strategies. Successful product launches depend on clear communication. Collaboration across teams enhances execution effectiveness. Chapters 00:00 The Hidden Side of Success in Life Sciences 06:27 Lessons from a Seasoned Strategist 13:00 The Importance of Cross-Functional Collaboration 18:54 Market Conditioning and Messaging Strategies 23:29 Navigating Challenges in a Complex Landscape 27:55 Advice for Biotech Founders on Commercialization 33:52 Navigating Launch Challenges 38:19 The Importance of Empathy in Strategy 45:45 Building Collaborative Partnerships

In this conversation, Jill Donahue discusses the importance of influence and engagement in everyday interactions, emphasizing that serving others is key to finding purpose and achieving effective communication.

In this enlightening conversation, Dr. Ivan Diaz-Padilla shares his journey from clinician to global oncology leader, discussing the unpredictable nature of cancer research, the emotional resilience required in oncology, and the complexities of drug discovery. He emphasizes the importance of biomarkers, the challenges of immuno-oncology, and the need for patient-centric clinical trials. The discussion also touches on the global disparities in cancer treatment access and the hopeful advancements in cancer care that may redefine the future of oncology. Chapters 00:00 The Unexpected Truths of Cancer Research 02:11 The Journey from Bedside to Boardroom 03:45 Inflection Points in a Medical Career 05:39 The Transition from Clinician to Industry 08:08 Emotional Resilience in Oncology 09:50 Understanding the Drug Development Process 12:59 The Evolution of Immuno-Oncology 17:46 The Complexity of Combination Therapies 22:24 The Role of Biomarkers in Personalized Medicine 26:10 Balancing Ethics and Rigor in Clinical Trials 30:37 Patient-Centric Approaches in Clinical Trials 35:25 Learning from Clinical Trial Failures 38:23 Transformational Insights from Setbacks 41:58 The Role of AI in Oncology 46:29 Closing the Global Gap in Cancer Access 48:54 Optimism for the Future of Cancer Care 53:02 Legacy and Contributions to Oncology

In this conversation, Ewelina Kurtys discusses her journey into biocomputing, a field that merges neuroscience and artificial intelligence. She explains the concept of biocomputing, the role of living neurons in computation, and the philosophical implications of AI and consciousness. The discussion also covers the challenges of programming neurons, safety concerns, and the future potential of biocomputing in various applications. Ewelina emphasizes the importance of ethical considerations and the collective responsibility of scientists to ensure that their work benefits society. Chapters 00:00 The Emergence of Biological Intelligence 02:32 Evelina Kotes: A Journey into Biocomputing 06:02 Philosophy of Intelligence and Consciousness 10:04 Understanding Biocomputing 15:39 Neurons: The Building Blocks of Intelligence 18:09 The Butterfly Experiment: A Living Demo 20:34 Misconceptions About AI and Biocomputing 23:18 Safety and Reproducibility in Biocomputing 25:22 Challenges of Neuron Longevity and Maintenance 26:46 The Human Side of Frontier Science 28:41 Energy Efficiency and Cost of Biocomputing 30:55 Emerging Use Cases for Biocomputing 32:04 Programming Neurons for Advanced Algorithms 35:39 The Future of Biocomputing and Its Impact 37:48 Quality of Neurons: Lab vs. Natural 39:31 Moments of Pride in Scientific Discovery 43:38 The Deeper Meaning of Biocomputing

In this conversation, Kaushik Trivedi interviews Dr. Aubrey de Grey, a prominent figure in longevity science, who challenges the conventional view of aging as an inevitable process. Dr. de Grey presents aging as an engineering problem that can be solved through advancements in technology, particularly in AI and nanotechnology. He discusses the concept of longevity escape velocity, where life expectancy could increase faster than aging, and emphasizes the interconnectedness of aging and diseases. The conversation also explores societal attitudes towards aging, the role of the pharmaceutical industry, and the moral obligation to address the suffering caused by aging. Dr. de Grey's vision for the future includes a shift in public perception and the potential for significant advancements in longevity research. 00:00 Challenging the Inevitability of Aging 02:28 Aubrey de Grey: A Visionary in Longevity Science 05:02 The Turning Point in Aging Research 06:17 Understanding Aging as Repairable Damage 08:00 Longevity Escape Velocity: A Mathematical Perspective 12:40 The Role of Nanotechnology and AI in Aging 15:48 Misunderstandings About Aging 17:12 The First Person to Live to a Thousand 19:11 The Seven Types of Aging Damage 24:06 Exciting Experiments in Aging Research 24:55 Integrating Components for Longevity Research 28:16 The Science of Caloric Restriction and Aging 29:56 The Psychological Barriers to Curing Aging 33:40 Navigating Skepticism in Aging Research 36:39 The Future of Longevity and Societal Change 39:32 Pharma's Role in Longevity Therapies 42:22 Reimagining Life with Extended Longevity 44:26 Aubrey De Grey's Vision for the Future 46:00 Key Messages on Aging and Suffering

Every 1.8 seconds, someone dies from heart disease, many of them never saw it coming.They were healthy, active, doing everything “right”… yet still at risk from the silent killer inside their arteries. In this powerful episode of Drug Diaries, host Kaushik Trivedi sits down with world-renowned cardiology expert Professor Maciej Banach to uncover the truth about cholesterol, heart disease, and prevention. Together, they explore: Why cholesterol isn’t the villain we think it is and what really makes it dangerous The crucial role of LDL cholesterol in atherosclerosis and heart attacks Why early detection and awareness can save millions of lives How innovations like gene editing and new cholesterol treatments are changing the future of heart health The lifestyle changes and small daily actions that can dramatically reduce your risk This conversation breaks down complex science into simple truths — helping you understand your body, your risks, and the steps you can take to protect your heart. 💡 Key Takeaways: Heart disease often strikes silently, without symptoms. Cholesterol is essential, but balance is everything. Awareness is prevention. Lifestyle and early testing save lives. Science is evolving fast but understanding remains our greatest tool. 🎙️ Chapters: 00:00 – The Silent Killer: Understanding Heart Disease 10:28 – Cholesterol: The Essential Molecule Misunderstood 21:08 – Early Detection: The Key to Prevention 25:39 – Innovations in Cholesterol Treatment 30:27 – Understanding LDL Cholesterol and Atherosclerosis 41:50 – The Multifaceted Nature of Cardiovascular Risk 48:56 – Bridging the Gap: From Knowledge to Action 55:48 – Personal Reflections and Motivations in Cardiology

Summary In this enlightening conversation, Carlos Eid shares his journey into medical affairs, emphasizing the importance of redefining impact beyond mere activity metrics. He discusses the evolving role of Medical Science Liaisons (MSLs), the integration of AI in medical affairs, and the significance of cultural sensitivity in leadership. Carlos also highlights the value of mentorship and personal growth, urging the next generation to find their purpose and remain resilient in their careers. His insights reflect a deep commitment to patient-centricity and the transformative potential of medical affairs in healthcare. Chapters 00:00 The Evolving Role of Medical Affairs 02:14 Personal Journeys in Medical Affairs 06:34 Rethinking Impact in Medical Affairs 15:39 Defining Exceptional MSLs 25:58 The Balance of Human Insight and AI 28:06 AI as an Enabler in Medical Writing 30:26 Leadership Across Cultures 34:21 The Importance of Mentorship 37:38 Evolution of Leadership Style 40:06 Addressing Non-Performance 42:43 Core Values and Personal Identity 47:27 Advice for the Next Generation in Medical Affairs

summary In this conversation, Kaushik Trivedi and Rohit Alimchandani discuss the transformative impact of technology on healthcare, emphasizing the importance of leadership, team dynamics, and the role of AI in enhancing patient experiences. Rohit shares insights from his career journey, leadership philosophy, and the future of healthcare innovation, highlighting the need for a connected ecosystem to drive efficiency and improve patient outcomes. Chapters 00:00 Transforming Healthcare: The Role of Technology 02:55 Rohit Alimchandani's Career Journey 05:48 Leadership Philosophy and Influences 09:34 Building High-Performing Teams in Healthcare Tech 12:13 AI and Patient Empowerment 17:29 The Future of Drug Development and AI 22:21 Creating a Pharma Operating System 25:40 The Five Pillars of Pharmaceutical Innovation 31:15 Building a Connected Ecosystem in Pharma 35:45 Overcoming Silos in Pharmaceutical Technology 40:17 Engineering Impact in Healthcare 44:52 Metaphors for Digital Transformation 46:57 Future Trends in Healthcare Innovation Explore how **ai in healthcare** is impacting **medical innovation** and the future of **health technology**. **Automation** is reshaping processes, while **digital health** solutions drive **healthcare innovation** forward. Join the discussion on the latest **technology** reshaping medicine.

The AI revolution is no longer a future headline, it’s unfolding right now in every lab, every clinical trial, and every boardroom across the life sciences industry. In this short, powerful episode, Kaushik Trivedi explores: 💡 How AI is already transforming drug discovery, clinical development, and regulatory operations ⚡ The roles most at risk, and those that will thrive 🧭 The 3 new rules to future-proof your career in pharma and biotech 🗓️ A 12-month tactical roadmap to build AI fluency and become indispensable If you work in pharma, biotech, or healthcare, this episode could redefine how you think about your career, your value, and your future. 🎧 Watch till the end for a surprise call-to-action: a free 12-month roadmap + details on an upcoming AI Academy for Life Sciences Professionals. 👉 Comment “ROADMAP” below to get your copy and start your transformation today. #AI #Pharma #Biotech #FutureOfWork #LifeSciences #DigitalTransformation #DrugDiaries

Many wonder, what is cancer? This video explores the complexities of cancer research and the challenges in finding effective cancer treatment. It highlights the importance of early diagnosis of cancer and understanding various cancer symptoms. The video also touches on the impact on the cancer patient and the role of clinical trials. In this conversation, Dr. Sav Solanki shares his extensive journey in oncology, discussing the evolution of cancer treatment, the importance of mentorship, and the cultural breakthroughs that have shaped the field. He emphasizes the significance of patient-centric approaches and the role of collaboration in advancing oncology. The discussion also touches on the challenges of drug development, the impact of immunotherapy, and the future of cancer treatment, highlighting the need for innovation and understanding the human element in healthcare. takeaways Oncology is not just about science; it's about people. Mentorship plays a crucial role in career development. The evolution of cancer treatment has been significant over the years. Cultural breakthroughs in oncology are as important as scientific ones. Immunotherapy is changing the landscape of cancer treatment. Patient-centric approaches are essential for effective care. Collaboration across sectors is vital for progress in oncology. AI and data are transforming drug discovery and patient outcomes. Safety must always be prioritized in treatment development. Networking and continuous learning are key to career success. Chapters 00:00 The Human Element in Oncology 01:26 Sav Solanki's Journey in Oncology 03:42 Choosing the Path of Oncology 06:36 Mentorship and Learning in Oncology 09:00 Evolution of Cancer Treatment 12:30 Cultural Breakthroughs in Oncology 13:24 Collaboration in Cancer Research 15:35 The Power of Immunotherapy 17:58 Simplifying Complex Concepts 21:15 Holistic Approaches to Cancer Management 23:19 Patient-Centric Focus in Oncology 26:33 The Future of Data and AI in Cancer Treatment 27:44 Patient-Centric Approaches in Oncology 29:55 Barriers in Oncology Drug Development 32:56 Navigating the Drug Development Pipeline 34:34 Trade-offs in Treatment Development 36:10 Equity and Access in Oncology 39:53 The Future of Cancer Treatment 45:17 Collaboration in Oncology 46:19 Career Advice in Oncology 49:05 Guiding Principles in a Career

In this episode of Drug Diaries, Geert Kersten, CEO of Cel-Sci, discusses the innovative approach of using immunotherapy, specifically Multikine, in cancer treatment. He emphasizes the importance of the immune system in fighting cancer and the need for a paradigm shift in how cancer therapies are developed and administered. The conversation covers the challenges faced in drug development, regulatory hurdles, and the potential impact of Multikine on head and neck cancer treatment. Geert also shares insights on the evolving healthcare landscape in Saudi Arabia and the future aspirations for Multikine and Cel-Sci. Chapters 00:00 The Journey of Immunotherapy in Cancer Treatment 09:24 Understanding Multikine and Its Impact on Head and Neck Cancer 18:56 The Science Behind Multikine: Mechanism and Administration 23:27 Navigating Challenges: Regulatory Hurdles and Market Dynamics 26:21 FDA Feedback and Study Design 29:21 Commercial Aspirations and Future Vision 31:36 Saudi Arabia's Healthcare Vision 2030 35:04 Breakthrough Designation Explained 37:40 Multikine's Role in Cancer Treatment 41:03 Dealing with Doubt and Investor Skepticism 44:53 The Future of Leap Platforms 46:48 Long-term Impact of Multikine

In this conversation, the speakers discuss the importance of balancing structure and freedom in customer interactions, particularly in sales roles. They emphasize the need for preparation and context to build meaningful relationships with customers, moving beyond transactional interactions. The discussion also touches on the challenges faced during customer appointments, the significance of understanding customer concerns, and the role of gender equality in leadership. The speakers advocate for creating a supportive environment for women in the workplace and highlight the impact of leadership on diversity and inclusion. They conclude with reflections on authenticity, listening, and resilience as key leadership philosophies. takeaways Make every interaction count to build strong relationships. Preparation and context are crucial for effective sales meetings. Focus on the customer's needs rather than just ticking boxes. Building relationships requires a holistic approach to customer interactions. Understanding customer concerns fosters trust and engagement. Gender equality in leadership is essential for progress. Supportive environments empower women in the workplace. Leaders should be held accountable for diversity and inclusion targets. Authenticity and listening are vital for effective leadership. Resilience is key; don't compromise on your beliefs. Chapters 00:00 Balancing Structure and Freedom in Customer Interactions 02:20 The Importance of Preparation and Context in Sales Meetings 05:14 Building Relationships Beyond Transactions 08:05 Navigating Customer Appointments and Expectations 10:36 Understanding Customer Concerns and Community Engagement 13:38 Gender Equality and Leadership Challenges 16:04 Creating a Supportive Environment for Women in the Workplace 19:02 The Role of Authenticity in Leadership 21:46 Driving Change Through Accountability in Diversity Initiatives 25:13 Philosophy of Leadership and Resilience

In this conversation, Uday discusses the evolving landscape of leadership in the life sciences sector, emphasizing the importance of cultural collaboration, shared leadership, and the need for empathy and vulnerability in leadership roles. He highlights the challenges posed by hierarchical structures and the critical role of customer experience in healthcare. Uday also addresses the significant gap in diversity and inclusion within pharma leadership and advocates for a more authentic and inclusive approach to leadership. The discussion culminates in reflections on personal philosophies and actionable insights for fostering a more equitable future in the industry.

In this video, Dr. Arup Pramanik explains the crucial need to improve the **patient experience** so that new **drug development** efforts can have the greatest impact on the **patient journey**. They also emphasize the importance of using **artificial intelligence** and **ai** in **drug discovery** and **analytics** to speed access to vital medicines. takeaways Behind every life-saving medicine, there's a question of access. Market access is a complex mix of various expertise. Leadership requires honesty, empathy, and the ability to challenge. Innovation in healthcare must involve multiple stakeholders. AI can enhance patient care and improve healthcare outcomes. Health equity is crucial for inclusive healthcare access. Understanding the science and economics is key to market access. Building trust and relationships is essential for success. Success is measured by the growth of the teams you lead. Asking questions is vital for learning and growth. Chapters 00:00 The Battle for Market Access 02:44 Leadership Lessons from a Market Access Expert 05:34 Demystifying Market Access 08:10 Innovation in Pricing and Access Models 10:41 The Future of Healthcare: AI and Digital Transformation 13:56 Health Equity and Access in Low-Income Countries 16:39 Redesigning Market Access 19:07 Personal Growth and Leadership Philosophy 21:52 Measuring Success and Legacy 24:16 Advice for Future Leaders

Theory of Constraints, systems thinking, drug discovery, clinical trials, AI in pharma, organizational improvement, leadership, human potential, bottlenecks, healthcare innovation In this episode of Drug Diaries, Dr. Alan Barnard discusses the Theory of Constraints (TOC) and its application in high-stakes industries like pharmaceuticals. He emphasizes the importance of identifying and addressing the weakest link in a system to unlock human potential and improve overall performance. The conversation explores the challenges organizations face in recognizing constraints, the role of AI and robotics in overcoming bottlenecks, and the need for a shift in mindset to embrace new technologies and methodologies for continuous improvement. Chapters 00:00 The Reality of Life Science Challenges 02:07 Understanding the Theory of Constraints 05:54 Identifying and Managing Constraints 11:09 The Importance of Attention as a Resource 17:23 The Challenge of Improving Systems 21:01 Recognizing and Resolving Constraints 24:21 Applying TOC to Clinical Trials 28:24 TOC for Continuous Improvement in Successful Companies 30:29 Understanding Inventory Management and Flow 33:20 The Theory of Constraints: Mindset and Application 35:14 AI and Robotics: Transforming Capacity Constraints 36:53 Digital Twins: The Future of Drug Testing 39:05 Overcoming Limitations with Technology 42:15 Courage to Focus on What Matters 44:26 Redefining Success: Personal and Professional Goals I look forward to receiving your feedback! Many thanks Kaushik

In this conversation, Florian Schnappauf discusses the evolving landscape of the pharmaceutical industry, emphasizing the need for a shift in mindset and strategy as companies prepare for an influx of product launches by 2030. He highlights the importance of connected functions, the role of AI in enhancing customer engagement, and Veeva's strategic move to its own Vault platform for CRM. The discussion also covers the challenges posed by specialty medicines, the necessity of effective content management, and the importance of a unified view of healthcare professionals to improve interactions. Schnappauf concludes with insights on the future of pharma operations and the mindset shifts required for success. Chapters 00:00 The Future of Pharma: A Crossroad 02:36 Transforming Mindsets in Life Sciences 04:57 The 2030 Launch Challenge 08:07 Specialty Medicines: A Dual Challenge 10:41 Risks of Traditional Launch Playbooks 13:19 Connecting Functions for Smarter Launches 16:04 Creating a Unified View of HCPs 18:36 Enhancing HCP Experience Through Technology 21:22 The Role of Content in Pharma Engagement 23:50 The Impact of AI on Pharma Interactions 26:31 Viva's Strategic Move to Vault Platform 30:32 Innovating for the Life Sciences Industry 34:22 Milestones in Vault CRM Adoption 36:07 Customer Feedback and Migration Challenges 38:29 The Role of AI in CRM 41:30 Practical AI Applications in CRM 45:56 Voice Control and Compliance Innovations 49:54 Campaign Manager and Service Center Innovations 55:06 Mindset Shifts for Pharma Leaders by 2030 56:50 Redesigning Pharma Launch Strategies

In this conversation, Thane Wetting, CEO of Fibrogen, shares his journey from academia to leading a biotech company focused on innovative treatments for oncology and anemia. He discusses the challenges and opportunities in transitioning from big pharma to a nimble biotech environment, emphasizing the importance of patient-centricity, leadership, and resilience. Thane reflects on the current biotech landscape, the role of the FDA, and the significance of maintaining a clear mission amidst market volatility. He also offers insights into investor relations and the importance of having the right people in the right roles to drive success. Chapters 00:00 The Mission Behind Fibrogen 02:18 Thane Wetting's Career Journey 16:58 Transitioning from Big Pharma to Biotech 21:02 Leadership Transition at Fibrogen 30:22 Understanding Prostate Cancer 33:05 Sustaining Core Values During Change 36:09 Navigating Organizational Change and Virtual Transition 38:33 Innovations in Oncology: ADC and Imaging Agents 42:07 Global Expansion and Commercialization Strategies 45:30 Balancing Scientific Ambition with Commercial Realism 49:21 Navigating a Cautious Capital Environment 51:40 FDA Interactions and Regulatory Responsiveness 53:42 Investor Behavior and Risk Management 56:02 Reflections on Career Lessons and Personal Growth 59:25 Advice for Emerging Leaders in Biotech 01:03:29 Staying True to Purpose in Biotech

The video shares the host's journey of starting a project with just a microphone and a desire to make something genuine and human. It highlights the value of **authenticity**, not just creating polished content, and the importance of **self reflection**. This project is meant to be a space for people, for stories, for **inspiration**, and for **self discovery journey**, emphasizing the value of **human interest** stories.

Every person knows someone whose journey ended prematurely due to cancer, but early detection could be a game changer. A simple blood test could provide an **early diagnosis** , offering hope where there was once despair. Learn about the latest in **cancer research** and what it means for the future of **health care**. Chapters 00:00 The Urgency of Early Cancer Detection 01:52 Susan Tousi's Journey to Biotech Leadership 04:13 The Intersection of Technology and Healthcare 07:19 Understanding Early Detection Misconceptions 09:57 How Blood Tests Detect Cancer 15:29 Democratizing Access to Cancer Screening 18:35 Balancing Innovation with Affordability 20:03 Leadership Challenges in Biotech 22:12 The Human Element in Biotech Leadership 26:34 The Impact of Time on Health and Relationships 30:10 Legacy Beyond Recognition 31:08 Redefining Fulfillment in Leadership 32:51 A Message of Optimism for the Future

keywords AI, life sciences, drug discovery, Genpact, healthcare, technology, transformation, regulatory affairs, innovation, patient experience summary In this episode of Drug Diaries, Kaushik Trivedi engages with Aaditya Gairola from Genpact to explore the transformative role of AI in the life sciences sector. They discuss the potential of AI to enhance drug discovery, streamline regulatory processes, and improve patient experiences. Aaditya shares his personal journey in the industry, the challenges faced by pharma companies, and the importance of data quality in AI applications. The conversation emphasizes the need for a cultural shift in organizations to embrace AI effectively and offers practical advice for leaders looking to integrate AI into their operations. Chapters 00:00 The AI Debate: Jobs vs. Enhancement 02:38 Introduction to Genpact and Its Impact 04:41 Aditya's Journey: From Telecom to Life Sciences 10:40 The Life Sciences Industry at a Crossroads 15:36 Genpact's Role in Life Sciences Transformation 19:14 Real-World Challenges in Pharma Today 24:01 What Sets Genpact Apart in Digital Transformation 26:26 AI's Role in Reshaping Life Sciences 26:31 AI Revolutionizing Drug Discovery 32:15 AI in Commercial Operations 37:11 Emerging AI Innovations in Life Sciences 43:01 Challenges in AI Adoption for Life Sciences 47:24 Guidance for Embracing AI in Organizations

Keywords N-Myristoyltransferase, cancer treatment, zelenirstat, drug development, protein regulation, antiviral drugs, cellular GPS, cancer biology, Pacylex Pharmaceuticals, clinical trials This video explains that cancer is more than just a tumor; it's a complex system. The video highlights how cancer cells disobey normal cellular rules, and continue to grow uncontrollably. It delves into the idea of targeting multiple **hallmarks of cancer** pathways simultaneously as a potential new approach to **cancer research**, with **immune evasion** being one of the key factors.

In this episode, Kaushik Trivedi engages with Carolina Quezada Correa, the global omnichannel operations lead at Grunenthal Group, discussing the evolving landscape of digital engagement in the pharmaceutical industry. They explore the importance of building meaningful connections through personalization, the integration of AI, and the necessity of data unification. Carolina shares her journey from public relations to leading omnichannel strategies, emphasizing the human element in digital interactions and offering valuable insights for aspiring professionals in the field. Chapters 00:00 Building Meaningful Connections in Pharma 00:57 Transforming Pharma with AI and Personalization 01:49 Building Meaningful Connections in Pharma 04:38 Carolina's Journey in Omnichannel Strategy 11:27 The Essence of Omnichannel in Pharma 15:43 Harnessing AI for Real-Time Personalization 26:02 Data Unification: The Key to Omnichannel Success 33:04 Balancing Automation and Human Connection 36:20 The Shift to Video Content in Pharma 38:46 The Future of Email and Digital Engagement 42:30 Exploring Live Shopping on TikTok 43:14 The Next Frontier in Omnichannel Engagement 44:25 Advice for Aspiring Professionals in Pharma 48:03 The Importance of Soft Skills in the Digital Age

summary In this conversation, Kaushik Trivedi speaks with Emma Hyland, VP of Strategy for Commercial Content at Veeva Systems, about the transformative role of technology in the pharmaceutical industry. They discuss how Veeva is redefining content management, the importance of AI in streamlining processes, and the need for a unified content taxonomy. Emma shares insights on her role, the challenges faced by the industry, and the future of content strategy in life sciences. In this conversation, Emma Hyland and Kaushik Trivedi explore the evolving landscape of medical affairs and content strategy in the pharmaceutical industry. They discuss the shift towards more strategic roles for medical affairs, the importance of effective content management, and the integration of technology to enhance efficiency. Emma shares insights on the MLR process, transformative case studies, and the future of content in life sciences, emphasizing the need for quality over quantity. The conversation also touches on the role of AI and the importance of collaboration in driving meaningful change within traditional organizations. Chapters 00:00 The Quiet Force Behind Pharma Content 01:49 Emma Hyland: A Leader in Pharma Transformation 07:57 The Intersection of Content, Data, and Technology 11:12 Veeva Solutions: More Than Just Content Management 15:10 The Importance of Content Taxonomy 19:03 Revolutionizing MLR Processes with AI 22:51 Advice for Implementing AI in Pharma 24:47 Evolving Roles in Content Creation 26:48 Emerging Skill Sets in Medical Affairs 27:00 The Shift in Medical Affairs' Role 28:59 Transformative Case Studies in Pharma 33:05 Understanding the MLR Process 37:17 Unlocking Content Efficiency in Pharma 41:00 The Future of Content in Life Sciences 43:27 Preparing for Innovations in Pharma 45:45 Trends in Content and Compliance 48:12 The Role of AI in Pharma 50:07 Driving Change in Traditional Organizations This video discusses the challenge of underutilized medical **content creation**, noting that a large percentage goes unseen. The discussion highlights a company impacting what doctors see, emphasizing the importance of effective **health literacy** and **patient education**. Discover the keys to successful **healthcare marketing** and **digital marketing** for better reach and engagement in the medical field, with a focus on **social media marketing**.